We are thrilled that our FLEXIQuant-LF paper has been accepted @eLife. This software maps and quantifies post translationally modified peptides without the use of heavy labelled standards. This expands FLEXIQuant to label-free large-scale proteomics data.https://t.co/XsjUddu1o5
One of my former students asked me for help with their biology final exam so of course I remixed @theestallion's Body song into #Antibodyody to teach a little about antibodies and the immune response. A quick little song from your favorite scientist #body 😂
Excited to share our study published in @CellCellPress. In this manuscript we show how the different stages of #Alzheimer's Disease in the human brain are reflected in the chemistry of #Tau protein, which is associated with cognitive decline.
https://t.co/tp45e0gTfu
The Steen lab has just started working on organizing the first 1000 COVID-19 plasma samples here at Boston Children’s Hospital, part of a large NIAID sponsored IMPACC study on SARS-CoV-2. @hipcproject@PrecVaccines@EPICVaccines#COVID19#BCH
We are happy to announce that our paper on the plasma proteome during the first week of life has been published in Frontiers in Immunology! We want to thank everyone involved in this great project: @PrecVaccines, @EPICVaccines
https://t.co/XHuxHK0qHI
The Steen lab is now on Twitter! Follow us to find out about the lab, current projects, and science at the intersections of bioinformatics, mass spectrometry, high throughput proteomics, biomarker development, and neurodegenerative disorders